Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 3 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 8 Uterine Cervical Neoplasms 4 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Advanced Solid Tumors 4 Lung Neoplasms 3 Carcinoma, Renal Cell 3 Urinary Bladder Neoplasms 2 Solid Tumor 2 Ovarian Neoplasms 2 Neoplasms 2 Melanoma 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Adenocarcinoma Of Esophagus 2 Triple Negative Breast Neoplasms 1 Solid Tumors 1 Solid Tumor, Unspecified, Adult 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Multiple Myeloma 1 Metastatic Urothelial Cancer 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Kidney Neoplasms 1 Erythrocytosis, Familial, 4 1 Endometrial Neoplasms 1 Carcinoma, Merkel Cell 1

Interventions

Gemcitabine 205 130-nm albumin-bound paclitaxel 84 Albumin-Bound Paclitaxel 57 pembrolizumab 44 Fluorouracil 41 Leucovorin 34 Oxaliplatin 33 Capecitabine 25 Nivolumab 22 Irinotecan 19 Bevacizumab 17 Paclitaxel 16 Cyclophosphamide 15 Cetuximab 15 Taxes 13 Erlotinib Hydrochloride 13 Drug Therapy 13 Carboplatin 13 irinotecan sucrosofate 11 Injections 10 Cisplatin 10 fludarabine 8 Pemetrexed 8 ALT-803 8 spartalizumab 7 olaparib 7 avelumab 7 Docetaxel 7 ruxolitinib 6 TH 302 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Pancreatic Neoplasms × zimberelimab × Clear all

NCT04104672 2026-06-02

ARC-8

Arcus Biosciences, Inc.

Phase 1 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡